The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,971
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Dillman, R. O., Seagren, S. L., Propert, K. J., Guerra, J., Eaton, W. L., Perry, M. C., Carey, R. W., Frei, E. F., & Green, M. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231403 · Cited by 1,153
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
Debbas, M., & White, E. (1993) · Genes & Development · doi:10.1101/gad.7.4.546 · Cited by 871
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., & Costa, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4495 · Cited by 848
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Self-citationFujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen‐Schaub, L. B., & Roth, J. A. (1994) · PubMed · Cited by 464
Self-citationMutations of p53 and ras genes in radon-associated lung cancer from uranium miners
Vahakangas, K. H., Metcalf, R. A., Welsh, J. A., Bennett, W. P., Harris, C. C., Samet, J. M., & Lane, D. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90866-2 · Cited by 316
Sundaresan, V., Ganly, P. S., Hasleton, P. S., Rudd, R., Sinha, G., Bleehen, N. M., & Rabbitts, P. H. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90371-4 · Cited by 257
p53 gene mutations in Barrett's epithelium and esophageal cancer.
Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., & Roth, J. A. (1991) · PubMed · Cited by 257
Self-citationZhang, W. W., Fang, X., Mazur, W. M., French, B. A., Georges, R. N., & Roth, J. A. (1994) · PubMed · Cited by 257
Self-citationGoyette, M. C., Cho, K., Fasching, C. L., Levy, D. B., Kinzler, K. W., Paraskeva, C., Vogelstein, B., & Stanbridge, E. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1387 · Cited by 243
Liu, T.-J., Zhang, W., Taylor, D. L., Roth, J. A., Goepfert, H., & Clayman, G. L. (1994) · PubMed · Cited by 241
Self-citationComprehensive Criteria for Assessing Therapy-Induced Toxicity
Ajani, J. A., Welch, S. R., Raber, M. N., Fields, W. S., & Krakoff, I. H. (1990) · Cancer Investigation · doi:10.3109/07357909009017560 · Cited by 232
Fujiwara, T., Cai, D. W., Georges, R. N., Mukhopadhyay, T., Grimm, E. A., & Roth, J. A. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.19.1458 · Cited by 219
Self-citationTakahashi, T., Carbone, D. P., Takahashi, T., Nau, M. M., Hida, T., Linnoila, I. R., Ueda, R., & Minna, J. D. (1992) · PubMed · Cited by 199
Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA
(1991) · Lung Cancer · doi:10.1016/0169-5002(91)90412-y · Cited by 188
Cornetta, K. G., & Anderson, W. F. (1989) · Journal of Virological Methods · doi:10.1016/0166-0934(89)90132-8 · Cited by 152
Cai, D. W., Mukhopadhyay, T., Liu, Y., Fujiwara, T., & Roth, J. A. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.5-617 · Cited by 124
Self-citationZhang, Y., Mukhopadhyay, T., Donehower, L. A., Georges, R. N., & Roth, J. A. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-451 · Cited by 114
Self-citationSchneider, P. M., Casson, A. G., Levin, B., Garewal, H. S., Hoelscher, A. H., Becker, K., Dittler, H. J., Cleary, K. R., Troster, M., Siewert, J. R., et al. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70441-5 · Cited by 110
Self-citationKitamura, H., Kameda, Y., Nakamura, N., Nakatani, Y., Inayama, Y., Iida, M., Noda, K., Ogawa, N., Shibagaki, T., & Kanisawa, M. (1995) · Europe PMC (PubMed Central) · Cited by 93
Tamiya, T., Mx, W., Chase, M., Ono, Y., Lee, F., Breakefield, X. O., & Chiocca, E. A. (1995) · PubMed · Cited by 32
Cited by
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Metadata
- Authors
- Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M. W., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C.-I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., Mcdonnell, T. J., Mukhopadhyay, T., & Cai, D.
- Venue
- Nature Medicine
- Published
- 1996-09
- Volume
- 2
- Issue
- 9
- Pages
- 985-991
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1990406980
- Cited by
- 703
- References
- 33
- FWCI
- 38.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.